KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Cash & Equivalents (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Cash & Equivalents for 7 consecutive years, with $261.8 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 41.6% to $261.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $261.8 million through Dec 2025, down 41.6% year-over-year, with the annual reading at $261.8 million for FY2025, 41.6% down from the prior year.
  • Cash & Equivalents hit $261.8 million in Q4 2025 for GoodRx Holdings, down from $273.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $990.5 million in Q1 2021 to a low of $261.8 million in Q4 2025.
  • Historically, Cash & Equivalents has averaged $641.9 million across 5 years, with a median of $729.7 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: surged 933.49% in 2021 and later plummeted 46.69% in 2024.
  • Year by year, Cash & Equivalents stood at $941.1 million in 2021, then dropped by 19.55% to $757.2 million in 2022, then fell by 11.21% to $672.3 million in 2023, then crashed by 33.31% to $448.3 million in 2024, then tumbled by 41.6% to $261.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for GDRX at $261.8 million in Q4 2025, $273.5 million in Q3 2025, and $281.3 million in Q2 2025.